ERIN Summit Brought Together Patients and Their Families, Offering a Space to Learn, Connect, Feel Supported
EHC – European Haemophilia Consortium shared a post on LinkedIn:
“From 5 to 7 December, we proudly hosted the ERIN Summit in Berlin, Germany. This annual event brings together patients with extremely rare bleeding disorders and their families, offering a unique, family-friendly space to learn, connect, and feel supported.
This year’s programme focused on treatment updates, unmet needs, and lived experiences. Through open discussions and interactive workshops, we strengthened knowledge within the community and built a foundation for continued learning and collaboration.

The tradition of the ERIN summit reflects a long-standing dedication to empowering this community with practical information and advocacy tools. A heartfelt thank-you goes to the ERIN Committee for their ongoing commitment to making patients with extremely rare bleeding disorders more visible and heard. By sharing knowledge and amplifying patient stories, we aim to ensure no one is left behind!
Learn more about the EHC ERIN here”
Get the latest updates with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers